FDA approves first weight-loss pill
The Food and Drug Administration approved the first-ever weight-loss pill on Monday, a move that is set to greatly expand the industry.
TL;DR
- The FDA approved the first-ever weight-loss pill.
- The pill is a tablet formulation of Novo Nordisk's popular Ozempic and Wegovy injections.
- The oral version is expected to increase the drug's usage due to convenience.
- The pill is set to launch in the United States in early January, starting at $149 a month for the first dose.
- Novo Nordisk CEO Mike Doustdar stated the pill offers a convenient, once-daily option for weight loss equivalent to the original injection.
- The weight loss achieved with the pill in tests was equivalent to that of the injections, as both contain semaglutide.
- The article mentions President Donald Trump and his administration's efforts to lower costs and expand the use of GLP-1 drugs like Ozempic to combat obesity.
- Trump recently made deals with Novo Nordisk and Eli Lilly to lower prices and expand Medicare coverage for their weight loss and diabetes medications.